drugset / Trial / NCT00579098

The Use of Statins Following a Left Atrial Catheter Ablation Procedure to Prevent Atrial Fibrillation

NCT00579098 ↗

Phase 4 Completed 125 enrolled Mayo Clinic Pfizer · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

To investigate whether statin therapy utilizing the drug Lipitor (atorvastatin) might be effective in preventing short-and long-term atrial fibrillation (AF) following a left atrial ablation procedure. We further hypothesize this reduction will result from diminished peri-procedural inflammation, which will be reflected in lower C-Reactive Protein (CRP) values in the blood.

Timeline

Start
2007-12
Primary completion
2011-12
Completion
2011-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atorvastatin Small molecule 80 mg Oral

Indications